hTERT

Human telomerase reverse transcriptase (hTERT) is a critical enzyme that plays a central role in cellular aging and cancer biology. It is the catalytic component of the telomerase complex, which adds repetitive DNA sequences (TTAGGG) to the ends of chromosomes, known as telomeres. This process is essential for maintaining telomere length, which is crucial for the stability and longevity of cells.

hTERT is a crucial player in cancer biology, facilitating tumor growth and metastasis through its role in telomere maintenance and interaction with various signaling pathways. hTERT expression is often upregulated in cancerous cells, with studies indicating that it is present in over 85% of tumors, while normal somatic cells typically exhibit low or absent levels of hTERT. This overexpression allows cancer cells to evade senescence and apoptosis, contributing to their immortalization and uncontrolled proliferation. The association between hTERT and cancer was of paramount concern as many hypothesised that hTERT gene therapy would spawn new cancers.

EFFECTS

  • Repairs and lengthens telomeres
  • Increases lifespan
  • Maintains bone health
  • Improves glucose tolerance
  • Reduces neuromuscular decline
  • Improves mitochondrial health
  • Improves genomic stability reducing mutations
  • Reduces senescence cell burden
  • Reduces the chance of cancer
  • Reverses biological aging

Supporting Scientific Literature

We have assembled the following short collection of published scientific manuscripts regarding hTERT gene therapy.

Eternal Youth: A Comprehensive Exploration of Gene, Cellular, and AAV Therapies

This article discusses the potential of AAV-mediated gene therapies, particularly focusing on hTERT and Klotho gene transfer for anti-aging applications. It highlights the use of AAV vectors in delivering genes that could enhance longevity and address age-related diseases. The article emphasizes the safety and efficacy of AAVs in clinical applications, making them promising tools for gene therapy aimed at combating aging and associated conditions.

https://doi.org/10.3390%2Fijms25010643

Telomere Gene Therapy: Polarizing Therapeutic Goals for Treatment of Aging

This study investigates the use of AAV vectors to deliver the TERT gene in a murine model. The research demonstrated that AAV9, which effectively transduces various tissues, could extend the lifespan of mice by improving age-related conditions such as osteoporosis and glucose intolerance. Importantly, the study found that AAV9-mediated TERT expression did not increase cancer incidence, suggesting a potentially safe approach to telomerase gene therapy for aging.

https://doi.org/10.3390%2Fcells8050392

Adeno-associated virus as a delivery vector for gene therapy of human diseases

This review article provides a comprehensive overview of AAV biology and its applications in gene therapy. It discusses the advantages of AAVs, such as their minimal pathogenicity and ability to establish long-term gene expression. The article highlights ongoing clinical trials utilizing AAV vectors for various diseases, including potential applications for hTERT gene therapy. It also addresses challenges related to immune responses and the need for improved manufacturing methods for AAV-based therapies.

https://doi.org/10.1038/s41392-024-01780-w

Systemic Human hTERT AAV Gene Transfer Therapy and the Effect on Telomere Length and Biological Age

This case report details the effects of AAV hTERT gene transfer therapy in a single adult female over 5.8 years. Following treatment, telomere length increased significantly, suggesting a reversal of biological age. The study reported no adverse effects or complications associated with the therapy, indicating its potential as a safe and effective intervention for telomere lengthening and age-related health improvements.

https://doi.org/10.37191/Mapsci-2582-385X-4(2)-106

Safety study of AAV hTert and Klotho gene transfer therapy for dementia – focuses on – activation of telomerase thru AAAV hTERT gene therapy. The study highlights the role of cellular senescence in Alzheimer’s disease, where the accumulation of senescent cells contributes to neurodegeneration. By using gene therapy to rejuvenate cells, it is posited that cognitive decline may be slowed or reversed. Preliminary findings suggest that AAV hTert and Klotho gene transfer therapies are safe and may have therapeutic potential in improving memory and cognitive function in models of Alzheimer’s disease.

https://doi.org/10.37191/Mapsci-2582-385X-3(6)-097